Title: System validation at the KKS Cologne a practical approach
1System validation at the KKS Cologne a
practical approach
- MACRO User Group Meeting
- 26.-27. Mai 2004Edinburgh, Scotland
- Thomas Bratke, Andreas Gassmann, Ingrun
Leyendecker Coordination Centre for Clinical
Trials Cologne,University Hospital Cologne,
Germany
2List of Abbreviations
- KKS Coordination Centre for Clinical Trials
- BMBF German Ministry of Education and Research
- TMF Telematics Platform for German Medical
Research Networks - GCP Good Clinical Practice
- GMP Good Manufacturing Practice
- ER Electronic Record
- ES Electronic Signature
3Content
- German KKS general background information
- Regulatory affairs a short overview
- Practical approach to system validation
- Discussion
4German KKS general background information
- scope -
- supporting scientifically-driven ("investigator
sponsored") non-profit clinical trials - initiating, planning and performing innovative
and competitive national and international
clinical trials - implementation of harmonized quality management
- training related to scientific and organizational
aspects of trials (e.g. study nurse courses,
investigator courses) - long-term establishment of the coordination
centres with universitysupport and
pharmaceutical industry cooperation
5German KKS general background information
- locations -
Government funding
BMBF
6German KKS general background information
- modules available for profit and non-profit
organizations -
- project management
- monitoring
- clinical trail assistance (i.e. study nurses)
- statistics
- data management
7Content
- German KKS general background information
- Regulatory affairs a short overview
- Practical approach to system validation
- Discussion
8Regulatory affairs a short overview
- imposed regulations -
- ICH GCP (International Conference on
Harmonization), 1996 E6 Guideline for Good
Clinical Practice - EU Guide to Good Manufacturing Practice, Volume
4 - Annex 11 Computerized Systems, 1998
- Annex 15 Qualification and Validation, September
2001 - EU Directive 2001/20/EC
- FDA 21 CFR Part11 Electronic Records Electronic
Signatures Final Rule, Federal, March 20, 1997 -
9Regulatory affairs a short overview
- EU Directive 2001/20/EC -
- standardization of procedures for ethical and
competent authority consideration and
authorization - GCP standards for commencing and conducting
clinical trials - Good Manufacturing Practice (GMP) standards for
medicines used in clinical trials - inspections against internationally accepted
principles and standards of GCP and GMP,
supported by enforcement powers
10Regulatory affairs a short overview
- EU Directive 2001/20/EC implementation -
- United Kingdom
- 'the Medicines for Human Use (Clinical Trials)
Regulations 2004' (SI 2004 No. 1031) that
implement the Clinical Trials Directive were laid
before both Houses of Parliament on 1 April 2004
and came into force on 1 May 2004. - Germany
- the 12th amendment of the German Medicines Law
was not accepted by the Federal Council
(14.5.2004) - further modifications will be discussed at the
Arbitration Commission (before summer 2004) -
11Regulatory affairs a short overview
- FDA 21 CFR Part 11 -
- Draft Guidance for Industry 21 CFR Part11 ERES,
Validation, August 2001 - Draft Guidance for Industry 21 CFR Part11 ERES,
Glossary of Terms, August 2001 - Draft Guidance for Industry 21 CFR Part11 ERES,
Time Stamps, February 2002 - Draft Guidance for Industry 21 CFR Part11 ERES,
Maintenance of ER, July 2002 - Draft Guidance for Industry 21 CFR Part11 ERES,
Electronic Copies of ER, August 2002 - Draft Guidance for Industry Part 11 ERES, Scope
and Application, February 2003 - Guidance for Industry Part 11 ERES, Scope and
Application, August 2003 - risk based approach
12Regulatory affairs a short overview
- leading questions -
- How can a small organization fulfill its
responsibility to the various regulatory
requirements? - Specifically, how can a validated computer
system in data management be implemented and
maintained? - available time period
- available qualified employees
- total costs
-
13Content
- German KKS general background information
- Regulatory affairs a short overview
- Practical approach to system validation
- Discussion
14Practical approach to system validation
- local interpretation of computer system
validation -
- computer system validation will be restricted to
the usage and requirements of the MACRO computer
system - whole System Life Cycle of the MACRO computer
system must be considered (planning, development,
implementation, documentation, operation,
inspection, changing) - emphasis on usage of the MACRO computer system in
central operational business (i.e. data
management in clinical trials and patient
registers) - In-house data management
- EDC online data management
- EDC offline data management
15Practical approach to system validation
- the validation project (validation master plan)
-
- EDC computer software evaluation and
recommendations - EDC computer software development
- EDC computer software usage
- risk based analyses
- change management (in planning)
16Practical approach to system validation
- EDC computer software evaluation and
recommendations -
- procedure (performed by TMF and KKS Duesseldorf)
- evaluation of 40 EDC software products
- vendor presentations and detailed analysis of 15
EDC software products - recommendation of 3 EDC software products
- recommended software products (open source and
commercial) - PhOSCo (Pharma Open Source Community)
- eResearch Network, eResearch Technology,
Philadelphia - MACRO, InferMed, London
17Practical approach to system validation
- EDC computer software development -
- commercial EDC computer software is developed and
documented according to a quality assurance
process - audit at software vendor
- software vendor promotes exchange of experience
in computer system software (workshops, training,
hotline, support) - limitations on EDC computer software will be
communicated and addressed by local SOPs or
working instructions
18Practical approach to system validation
- EDC computer software usage -
- Risk based approach
- The risk-based approach refers to the application
of risk analysis principles to manage inspection
programs. It has been used in the nuclear power
generation industry for some time and is also
employed in refineries and petrochemical plant.
The ultimate goal is to develop a cost-effective
inspection and maintenance program that provides
assurance of acceptable integrity and
reliability. - Risk is defined as the combination of probability
and consequence. Probability is the likelihood of
a failure occurring and consequence is a measure
of the damage that could occur as a result of the
failure. - An increased risk is resulting from an increased
probability and a higher degree of consequence.
19Practical approach to system validation
- EDC computer software usage -
- Risk based approach
- process field and function description
- description of (system) failure or error
- error causes
- risk level (1low, 2medium, 3high) depending on
- occurrence (A)
- GCP relevance (B)
- time interval between occurrence and detection
(E) - measures (standard operating procedures, working
instructions, manuals, logs, etc.)
20Practical approach to system validation
- risk based approach example 1 -
21Practical approach to system validation
- risk based approach example 2 -
22Practical approach to system validation
- change management (in planing) -
- What can change during EDC computer software
usage? - personal
- hardware
- project specifications
- MACRO software versions
- MACRO software patches
- What are the differences between new and running
EDC computer software projects? - Thank you for your attention !
23Discussion
- System validation at the KKS Cologne a
practical approach -
- Thank you for your attention